CMIC

Pharmaceutical Value Creator
日本語については、日本語ページをご覧ください。

[CMIC @CMIC_Group]

CMIC is honored to be recognized as the Winner of the 2025 @Citeline Japan Awards for Best Contract Development Manufacturing Organization (CDMO). Learn more about the Citeline Japan Awards: https://t.co/ofWttSgwhR

[CMIC @CMIC_Group]

Join CMIC at BLPN’s Japan Access Forum in San Diego!

This session is focused on Japan–US life sciences collaboration, including investment, operational partnerships, and cross-border deal-making.

Scan the QR code or click the link below for details: https://t.co/OEjvoSoD5h

[CMIC @CMIC_Group]

DIA China 2026 is underway!

Day 1 was a great opportunity for the CMIC team to connect with industry leaders, partners, and innovators shaping the future of drug development across Asia and beyond.

Visit the CMIC team at our booth #DIAChina

[CMIC @CMIC_Group]

🏆 CMIC Group wins the Fierce Outsourcing Award for Clinical Trial Management.

With deep expertise in Japan & APAC, we help sponsors accelerate timelines, improve enrollment, and deliver high-quality outcomes.

Learn more: https://t.co/jUZAx3HxCZ

#ClinicalTrials #FierceAwards

[CMIC @CMIC_Group]

Join us at @MassBio for an engaging lunch & learn event on Unlocking Japan & APAC’s Competitive Edge 🌏

🗓 April 8 | 11:00 AM

Spots are limited—secure yours today: https://t.co/5HaVJIMmLJ

#ClinicalTrials #DrugDevelopment #APAC #JapanMarket #Biotech #MassBio

[CMIC @CMIC_Group]

CMIC is partnering with @bluenote_ai to bring agentic AI into clinical development workflows.

We aim to accelerate regulatory and clinical documentation by up to 75%, helping deliver innovative therapies to patients faster.

Learn more: https://t.co/nmqiaxaoWG

[CMIC @CMIC_Group]

Japan’s regulatory authority, the #PMDA, publishes a quarterly English newsletter sharing the latest information on new programs, policy direction, international collaboration, and key regulatory developments.

📩 Read here:
https://t.co/5yOEZomz6r

#DrugDevelopment #CMIC

[CMIC @CMIC_Group]

🎨 Starting today, 22 award-winning works from the 17th Nakamura Keith Haring Museum International Children’s Drawing Contest, co-hosted by the CMIC Group, are on display in front of the main reception at our headquarters in Tokyo, Japan!

[シミック公式 @CMIC_Official]

#シミック グループが共催する「第17回中村キース・へリング美術館 国際児童絵画コンクール」の受賞作品22点を、本日より本社総合受��前にて展示中です🎨
展示期間は来年1月15日（木）まで。
ご来社の際はぜひ、色彩豊かで感性あふれる作品の数々をご覧ください。
#絵画 #展示 #芸術の秋 #やさしさ

[CMIC @CMIC_Group]

harmo, a Personal Health Record (PHR) platform by #CMIC Group, joined the 20th Annual Congress of the Japanese Society for Quality and Safety in Healthcare in Kyoto. Ms. Natsuki Kodachi shared harmo’s initiatives to advance #PHR use for better medical information sharing.

[CMIC @CMIC_Group]

Press Release: CMIC has partnered with the Japanese Society for Inherited Metabolic Diseases to address “drug loss” in Japan—therapies approved abroad but unavailable domestically: https://t.co/GCkMJPOLpt

[CMIC @CMIC_Group]

CMIC is at #DIAJapan 2025 at Tokyo Big Sight, Booth 42/43! 🇯🇵

As a strategic partner to accelerate drug and medical device development in Asia, CMIC continues to support global companies across the entire development lifecycle

#CMIC #Pharma #Clinical #MedicalDevices

[Contract Pharma @ContractPharma]

We're excited to have @CMIC_Group as a Gold Sponsor who will be featured on the seatback covers during each session at the #ContractPharmaConference. Be sure to meet with their team at table 45.

Thank you for all your support, CMIC!

[CMIC @CMIC_Group]

📸 Highlights from last week's Keys to Succeeding in the Japanese Healthcare Market event, co-hosted by the Japan Society of Northern California and RAPS, with support from CMIC.

[CMIC @CMIC_Group]

Expanding to Japan’s healthcare market? Don’t miss this FREE event, sponsored by CMIC!

Learn more about “Keys to Succeeding in the Japanese Healthcare Market”: https://t.co/npax6n8hIU

#CMIC #Japan #Healthcare

[CMIC @CMIC_Group]

This week at CBA in Suzhou, China, Dr. Yoshimasa Shimoto led an insightful session covering key aspects of Japan’s regulatory landscape, PMDA processes, and early-phase clinical strategies.

Thank you to all the attendees who joined us!

#PMDA #Japan #CRO #DrugDevelopment #CBA

[CMIC @CMIC_Group]

CMIC’s recent OCT UK & Ireland presentation covered by @TrialsArena

Read the full report: https://t.co/zUqZrjSx9s

#OCTUK #Japan #SMO #ClinicalTrial #CMIC

[CMIC @CMIC_Group]

CMIC can act as an In-Country Clinical Caretaker (ICCC) for overseas sponsors

Learn More: https://t.co/FrUIrt6rYD

#ICCC #Japan #NHI #PMDA #CMIC #DrugApproval

[CMIC @CMIC_Group]

Did you know? Japan is one of the fastest countries for drug approvals worldwide — with a median of just 332 days from submission to authorization.
Get in touch with our regulatory experts to enter the Japan Market: https://t.co/jmKvWyO078

[CMIC @CMIC_Group]

We’re thrilled to share that CMIC Group has been named a finalist in the Fierce CRO Awards for "Excellence in Client Service and Partnership"!

Learn more: https://t.co/vzsLkgVV4j

#FierceCROAwards #FierceBiotech @FierceBiotech

[CMIC @CMIC_Group]

CMIC Group is headed to #BIO2025 in Boston, June 16–19!
📍Meet us at the Choose New Jersey Pavilion, Booth #364
Contact us to schedule a meeting: https://t.co/XE4FvYMKi9
#Biotech #ClinicalResearch #Pharma #Japan #APAC